BIOMAT Database Logo BIOMAT Database Logo

Cytomegalovirus infection during OKT3 treatment for renal allograft rejection. 1992

J D Morgan, and T Horsburgh, and A Simpson, and P K Donnelly, and P S Veitch, and P R Bell
Department of Surgery, Leicester General Hospital, United Kingdom.

UI MeSH Term Description Entries
D007108 Immune Tolerance The specific failure of a normally responsive individual to make an immune response to a known antigen. It results from previous contact with the antigen by an immunologically immature individual (fetus or neonate) or by an adult exposed to extreme high-dose or low-dose antigen, or by exposure to radiation, antimetabolites, antilymphocytic serum, etc. Immunosuppression (Physiology),Immunosuppressions (Physiology),Tolerance, Immune
D007677 Kidney Function Tests Laboratory tests used to evaluate how well the kidneys are working through examination of blood and urine. Function Test, Kidney,Function Tests, Kidney,Kidney Function Test,Test, Kidney Function,Tests, Kidney Function
D009894 Opportunistic Infections An infection caused by an organism which becomes pathogenic under certain conditions, e.g., during immunosuppression. Infection, Opportunistic,Infections, Opportunistic,Opportunistic Infection
D011183 Postoperative Complications Pathologic processes that affect patients after a surgical procedure. They may or may not be related to the disease for which the surgery was done, and they may or may not be direct results of the surgery. Complication, Postoperative,Complications, Postoperative,Postoperative Complication
D003586 Cytomegalovirus Infections Infection with CYTOMEGALOVIRUS, characterized by enlarged cells bearing intranuclear inclusions. Infection may be in almost any organ, but the salivary glands are the most common site in children, as are the lungs in adults. CMV Inclusion,CMV Inclusions,Congenital CMV Infection,Congenital Cytomegalovirus Infection,Cytomegalic Inclusion Disease,Cytomegalovirus Colitis,Cytomegalovirus Inclusion,Cytomegalovirus Inclusion Disease,Cytomegalovirus Inclusions,Inclusion Disease,Perinatal CMV Infection,Perinatal Cytomegalovirus Infection,Renal Tubular Cytomegalovirus Inclusion,Renal Tubular Cytomegalovirus Inclusions,Salivary Gland Virus Disease,Severe Cytomegalovirus Infection,Severe Cytomegalovirus Infections,Infections, Cytomegalovirus,CMV Infection, Congenital,CMV Infection, Perinatal,Colitis, Cytomegalovirus,Congenital CMV Infections,Congenital Cytomegalovirus Infections,Cytomegalic Inclusion Diseases,Cytomegalovirus Colitides,Cytomegalovirus Inclusion Diseases,Cytomegalovirus Infection,Cytomegalovirus Infection, Congenital,Cytomegalovirus Infection, Perinatal,Cytomegalovirus Infection, Severe,Cytomegalovirus Infections, Severe,Disease, Cytomegalic Inclusion,Disease, Cytomegalovirus Inclusion,Diseases, Cytomegalovirus Inclusion,Inclusion Disease, Cytomegalic,Inclusion Disease, Cytomegalovirus,Inclusion Diseases,Inclusion Diseases, Cytomegalovirus,Inclusion, CMV,Inclusion, Cytomegalovirus,Infection, Congenital CMV,Infection, Congenital Cytomegalovirus,Infection, Cytomegalovirus,Infection, Perinatal CMV,Infection, Perinatal Cytomegalovirus,Infection, Severe Cytomegalovirus,Perinatal CMV Infections,Perinatal Cytomegalovirus Infections
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D006084 Graft Rejection An immune response with both cellular and humoral components, directed against an allogeneic transplant, whose tissue antigens are not compatible with those of the recipient. Transplant Rejection,Rejection, Transplant,Transplantation Rejection,Graft Rejections,Rejection, Graft,Rejection, Transplantation,Rejections, Graft,Rejections, Transplant,Rejections, Transplantation,Transplant Rejections,Transplantation Rejections
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014019 Tissue Donors Individuals supplying living tissue, organs, cells, blood or blood components for transfer or transplantation to histocompatible recipients. Organ Donors,Donors,Ovum Donors,Semen Donors,Transplant Donors,Donor,Donor, Organ,Donor, Ovum,Donor, Semen,Donor, Tissue,Donor, Transplant,Donors, Organ,Donors, Ovum,Donors, Semen,Donors, Tissue,Donors, Transplant,Organ Donor,Ovum Donor,Semen Donor,Tissue Donor,Transplant Donor
D015774 Ganciclovir An ACYCLOVIR analog that is a potent inhibitor of the Herpesvirus family including cytomegalovirus. Ganciclovir is used to treat complications from AIDS-associated cytomegalovirus infections. BIOLF-62,BW-759,Cytovene,Ganciclovir Sodium,Ganciclovir, Monosodium Salt,Gancyclovir,RS-21592

Related Publications

J D Morgan, and T Horsburgh, and A Simpson, and P K Donnelly, and P S Veitch, and P R Bell
[OKT3 treatment of refractory renal allograft rejection].
April 1997, Zhonghua wai ke za zhi [Chinese journal of surgery],
J D Morgan, and T Horsburgh, and A Simpson, and P K Donnelly, and P S Veitch, and P R Bell
Orthoclone OKT3: a treatment for acute renal allograft rejection.
December 1987, ANNA journal,
J D Morgan, and T Horsburgh, and A Simpson, and P K Donnelly, and P S Veitch, and P R Bell
Orthoclone OKT3 treatment of acute renal allograft rejection.
April 1987, Transplantation proceedings,
J D Morgan, and T Horsburgh, and A Simpson, and P K Donnelly, and P S Veitch, and P R Bell
OKT3 treatment of steroid-resistant renal allograft rejection.
February 1987, Transplantation,
J D Morgan, and T Horsburgh, and A Simpson, and P K Donnelly, and P S Veitch, and P R Bell
OKT3 for the treatment of patients with acute renal allograft rejection.
April 1987, ANNA journal,
J D Morgan, and T Horsburgh, and A Simpson, and P K Donnelly, and P S Veitch, and P R Bell
OKT3 for the treatment of steroid-resistant acute renal allograft rejection.
January 1997, Nephron,
J D Morgan, and T Horsburgh, and A Simpson, and P K Donnelly, and P S Veitch, and P R Bell
Treatment of acute renal allograft rejection with OKT3 monoclonal antibody.
December 1981, Transplantation,
J D Morgan, and T Horsburgh, and A Simpson, and P K Donnelly, and P S Veitch, and P R Bell
Monoclonal antilymphocyte antibody (OKT3) treatment of acute renal allograft rejection.
January 1987, Pharmacotherapy,
J D Morgan, and T Horsburgh, and A Simpson, and P K Donnelly, and P S Veitch, and P R Bell
OKT3 treatment of cardiac allograft rejection.
January 1993, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation,
J D Morgan, and T Horsburgh, and A Simpson, and P K Donnelly, and P S Veitch, and P R Bell
Evolving use of OKT3 monoclonal antibody for treatment of renal allograft rejection.
December 1984, Transplantation,
Copied contents to your clipboard!